Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

New Data Confirms Cardiac Dimensions' Carillon® System Shows Favorable Long-Term Survival Rate In Patients With Functional Mitral Regurgitation

prnasiaFebruary 26, 2020

Tag: New data , Cardiac Dimensions , Functional Mitral Regurgitation

PharmaSources Customer Service